Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial.
Pettus J, Reeds D, Cavaiola TS, Boeder S, Levin M, Tobin G, Cava E, Thai D, Shi J, Yan H, Bautista E, McMillan J, Unger R, Henry RR, Klein S.
Pettus J, et al.
Diabetes Obes Metab. 2018 May;20(5):1302-1305. doi: 10.1111/dom.13202. Epub 2018 Jan 22.
Diabetes Obes Metab. 2018.
PMID: 29283470
Free PMC article.
Clinical Trial.